Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIG1 | P18858 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | DRD2 | P14416 | 1/20 | 0.42 |
| ▸ | DRD1 | P21728 | 1/20 | 0.42 |
| ▸ | DRD3 | P35462 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.41 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.41 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL132849 | 0.88 | LIG1 (0.63) | LIG1MAPK1HSD17B10KDM4ECYP3A4 | |
| SCHEMBL2470333 | 0.86 | LIG1 (0.54) | LIG1MAPK1HSD17B10KDM4ECYP3A4 | |
| SCHEMBL28543647 | 0.81 | DRD2 (0.44) | MAPK1HSD17B10KDM4EMAPTALOX15 | |
| SCHEMBL7386575 | 0.81 | RAB9A (0.57) | MAPK1HSD17B10KDM4EMAPTALOX15 | |
| SCHEMBL3942606 | 0.81 | LIG1 (0.54) | LIG1MAPK1HSD17B10KDM4EMAPT | |
| SCHEMBL10419379 | 0.81 | MAPT (0.49) | MAPK1HSD17B10KDM4EMAPTALOX15 | |
| SCHEMBL30876777 | 0.80 | THRB (0.55) | MAPK1HSD17B10KDM4EMAPTALOX15 | |
| SCHEMBL317182 | 0.80 | THRB (0.55) | MAPK1HSD17B10KDM4EMAPTALOX15 | |
| SCHEMBL28328204 | 0.80 | LIG1 (0.48) | LIG1MAPK1HSD17B10KDM4EMAPT | |
| SCHEMBL15766097 | 0.80 | CYP3A4 (0.44) | LIG1MAPK1HSD17B10KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119552298-A | Ageing-resistant organic silicon acrylate resin, preparation method and application | 东莞市雄驰电子有限公司 | 2025-03-04 | — | — | CN | disclosed |
| CN-106471043-B | UV-active chromophore functionalized polysiloxanes and copolymers made therefrom | 莫门蒂夫性能材料股份有限公司 | 2021-01-12 | — | — | CN | disclosed |
| EP-3164446-B1 | UV-ACTIVE CHROMOPHORE FUNCTIONALIZED POLYILOXANES AND COPOLYMERS MADE THEREFROM | MOMENTIVE PERFORMANCE MAT INC (US) | 2019-11-20 | — | — | EP | disclosed |
| EP-3164446-A1 | UV-ACTIVE CHROMOPHORE FUNCTIONALIZED POLYILOXANES AND COPOLYMERS MADE THEREFROM | Momentive Performance Materials Inc. (US) | 2017-05-10 | — | — | EP | disclosed |
| US-9562159-B2 | UV-active chromophore functionalized polysiloxanes and copolymers made therefrom | MOMENTIVE PERFORMANCE MATERIAL INC. (US) | 2017-02-07 | — | — | US | disclosed |
| WO-2016004287-A1 | UV-ACTIVE CHROMOPHORE FUNCTIONALIZED POLYILOXANES AND COPOLYMERS MADE THEREFROM | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2016-01-07 | — | — | WO | disclosed |
| US-20160002412-A1 | UV-ACTIVE CHROMOPHORE FUNCTIONALIZED POLYSILOXANES AND COPOLYMERS MADE THEREFROM | MOMENTIVE PERFORMANCE MATERIALS INC. | 2016-01-07 | — | — | US | disclosed |
| US-7074853-B2 | Photoprotective and lightfastness-enhancing siloxanes | XEROX CORPORATION (US) | 2006-07-11 | — | — | US | disclosed |
| US-6861458-B2 | Photoprotective and lightfastness-enhancing siloxanes | XEROX CORPORATION (US) | 2005-03-01 | — | — | US | disclosed |
| US-20050014951-A1 | Photoprotective and lightfastness-enhancing siloxanes | XEROX CORPORATION | 2005-01-20 | — | — | US | disclosed |
| US-6803395-B2 | POLYSILOXANE HAVING THEREON A HYDROPHILIC MOIETY AND A LIGHTFASTNESS MOIETY | XEROX CORPORATION | 2004-10-12 | — | — | US | disclosed |
| US-20030137570-A1 | Photoprotective and lightfastness-enhancing siloxanes | XEROX CORPORATION | 2003-07-24 | — | — | US | disclosed |
| US-20030133886-A1 | Photoprotective and lightfastness-enhancing siloxanes | XEROX CORPORATION | 2003-07-17 | — | — | US | disclosed |
| US-6569511-B1 | Polysiloxane having a hydrophilic moiety and a lightfastness moiety; ink jet coating | XEROX CORPORATION | 2003-05-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014951-A1 | Photoprotective and lightfastness-enhancing siloxanes | LRRFIP1, LRRC59, MMS19 | LIG1 66/4885MAPK1 3963/4885HSD17B10 2316/4885 |
| US-20030133886-A1 | Photoprotective and lightfastness-enhancing siloxanes | ITGA1, ITGB1, ITGB8 | LIG1 245/4885MAPK1 3444/4885HSD17B10 2627/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.